![β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study | BMC Cardiovascular Disorders | Full Text β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study | BMC Cardiovascular Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12872-020-01441-0/MediaObjects/12872_2020_1441_Fig1_HTML.png)
β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study | BMC Cardiovascular Disorders | Full Text
![Lack of Effect of Oral Beta-Blocker Therapy at Discharge on Long-Term Clinical Outcomes of ST-Segment Elevation Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention - ScienceDirect Lack of Effect of Oral Beta-Blocker Therapy at Discharge on Long-Term Clinical Outcomes of ST-Segment Elevation Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914910013652-gr1.jpg)
Lack of Effect of Oral Beta-Blocker Therapy at Discharge on Long-Term Clinical Outcomes of ST-Segment Elevation Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention - ScienceDirect
![β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute](https://www.ahajournals.org/cms/asset/717fdd76-a65b-4030-bc3c-68025a77cc12/jah32828-fig-0001.gif)
β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute
![Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study](https://smw.ch/index.php/smw/article/download/2851/version/2851/4647/14229/2120723351536103692_w20321_f1_conv.jpg)
Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study
![β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction | Journal of the American College of Cardiology β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/11a1df1d-9c94-4147-b0b0-c5f1b5a57485/fx1.jpg)
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction | Journal of the American College of Cardiology
![Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today? | Revista Española de Cardiología Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today? | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//18855857/0000006800000007/v1_201506221145/S1885585714004034/v1_201506221145/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w99KBUZDJuFlLjKo5clFAJaBzV3lXurjotj++nFCAYF1Nd9PGxDtl86eeObYuxNzwWnkuzoSLVJ8q4bnH18KplZIYR9C+DwI/77WKX2Icnksqq2CYk5bOhKzY5iDqKOT4+Fm8Bk9JHHuW3aQfLvUksrnBxqbYqhgKg6gAVI+aH8PCtxBCsWCvotQiifKW0RPhWYSvacMNsw+rxGF3H8OuGOxMMINu31TgwMeQM4zgvkRhjs1HYsB3FJQ77KqrzjLvPKN7HEV4qKPaGKx/L0+67/0=)
Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today? | Revista Española de Cardiología
Patient selection flowchart. BB = beta-blocker, LVEF = left ventricular... | Download Scientific Diagram
![Revaskularsierung bei akuten Koronarsyndromen. - Herz-Kreislauf-Krankheiten - MSD Manual Profi-Ausgabe Revaskularsierung bei akuten Koronarsyndromen. - Herz-Kreislauf-Krankheiten - MSD Manual Profi-Ausgabe](https://www.msdmanuals.com/-/media/manual/professional/images/c/v/s/cvs_approach_acs_algorithm_rev_de.gif?thn=0&sc_lang=de)
Revaskularsierung bei akuten Koronarsyndromen. - Herz-Kreislauf-Krankheiten - MSD Manual Profi-Ausgabe
![Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization | Scientific Reports Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-72232-y/MediaObjects/41598_2020_72232_Fig1_HTML.png)
Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization | Scientific Reports
![Topic Refresher: Acute Coronary Syndrome Medications : USMLE / Internal Medicine ABIM Board Exam Review Blog Topic Refresher: Acute Coronary Syndrome Medications : USMLE / Internal Medicine ABIM Board Exam Review Blog](https://knowmedge.com/blog/wp-content/uploads/2016/12/Blog-Acute-Coronary-Syndrome.png)
Topic Refresher: Acute Coronary Syndrome Medications : USMLE / Internal Medicine ABIM Board Exam Review Blog
![Frontiers | The Hypertension Paradox: Survival Benefit After ST-Elevation Myocardial Infarction in Patients With History of Hypertension. A Prospective Cohort- and Risk-Analysis Frontiers | The Hypertension Paradox: Survival Benefit After ST-Elevation Myocardial Infarction in Patients With History of Hypertension. A Prospective Cohort- and Risk-Analysis](https://www.frontiersin.org/files/Articles/785657/fcvm-09-785657-HTML/image_m/fcvm-09-785657-g001.jpg)
Frontiers | The Hypertension Paradox: Survival Benefit After ST-Elevation Myocardial Infarction in Patients With History of Hypertension. A Prospective Cohort- and Risk-Analysis
![Relationship Between β‐Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention | Journal of the American Heart Association Relationship Between β‐Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/56ac68b0-2910-43f0-999c-39ad43907c39/jah31880-fig-0001.gif)
Relationship Between β‐Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention | Journal of the American Heart Association
![β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study | The BMJ β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study | The BMJ](https://www.bmj.com/content/bmj/354/bmj.i4801/F1.large.jpg)